High frequency of t(14;18) in Hodgkin's lymphoma associated with follicular lymphoma

Pathology International

Volumn 62, Issue 8, 2012, Pages 518-524

  Yoshida, Maki ^a   Ichikawa, Ayako ^a   Miyoshi, Hiroaki ^a   Takeuchi, Masanori ^a   Kimura, Yoshizo ^a   Nino, Daisuke ^a   Ohshima, Koichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

BCL2; Follicular lymphoma; Hodgkin's lymphoma; T(14; 18)

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2;

ARTICLE; CHROMOSOME 14; CHROMOSOME 18; CHROMOSOME TRANSLOCATION; CLINICAL FEATURE; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS INFECTION; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; GENE FREQUENCY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; NF-KAPPA B; PARAFFIN EMBEDDING; PROTO-ONCOGENE PROTEINS C-BCL-2; REED-STERNBERG CELLS; RNA, VIRAL; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84864324793     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2012.02835.x     Document Type: Article

References (27)

1. Bargou R, Leng C, Krappmann D etal. High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. Blood 1996; 87: 4340-7.
2. Nakamura N, Ohshima K, Abe M etal. Demonstration of chimeric DNA of bcl-2 and immunoglobulin heavy chain in follicular lymphoma and subsequent Hodgkin lymphoma from the same patient. J Clin Exp Hematop 2007; 47: 9-13.
3. Isola J, Tanner M. Chromogenic in situ hybridization in tumor pathology. Mol Diagn Cancer 2004; 97: 133-44.
4. Espinet B, Bellosillo B, Melero C etal. FISH is better than BIOMED-2 PCR to detect IgH/BCL2 translocation in follicular lymphoma at diagnosis using paraffin-embedded tissue sections. Leuk Res 2008; 32: 737-42.
5. Gravel S, Delsol G, Al Saati T. Single-cell analysis of the t(14;18)(q32;q21) chromosomal translocation in Hodgkin's disease demonstrates the absence of this translocation in neoplastic hodgkin and reed-sternberg cells. Blood 1998; 91: 2866-74.
6. Louie DC, Kant JA, Brooks JJ etal. Absence of t(14;18) major and minor breakpoints and of Bcl-2 protein overproduction in Reed-Sternberg cells of Hodgkin's disease. Am J Pathol 1991; 139: 1231-7.
7. Stetler-Stevenson M. The t(14;18) translocation in Hodgkin's disease. J Natl Cancer Inst 1992; 84: 1770-1.
8. Gupta RK, Whelan JS, Lister TA etal. Direct sequence analysis of the t(14;18) chromosomal translocation in Hodgkin's disease. Blood 1992; 79: 2084-8.
9. Athan E, Chadburn A, Knowles DM. The bcl-2 gene translocation is undetectable in Hodgkin's disease by Southern blot hybridization and polymerase chain reaction. Am J Pathol 1992; 141: 193-201.
10. Bhagat SK, Medeiros LJ, Weiss LM etal. bcl-2 expression in Hodgkin's disease. Correlation with the t(14;18) translocation and Epstein-Barr virus. Am J Clin Pathol 1993; 99: 604-8.
11. Mitani S, Oka T, Aoki N etal. Rearrangement of bcl-2 is detectable in Hodgkin's disease by polymerase chain reaction. Jpn J Cancer Res 1994; 85: 1229-32.
12. Gupta RK, Lister TA, Bodmer JG. The t(14;18) chromosomal translocation and Bcl-2 protein expression in Hodgkin's disease. Leukemia 1994; 8: 1337-41.
13. LeBrun DP, Ngan BY, Weiss LM etal. The bcl-2 oncogene in Hodgkin's disease arising in the setting of follicular non-Hodgkin's lymphoma. Blood 1994; 83: 223-30.
14. Kneba M, Eick S, Herbst H etal. Low incidence of mbr bcl-2/JH fusion genes in Hodgkin's disease. J Pathol 1995; 175: 381-9.
15. Nolte M, Werner M, Spann W etal. The bcl-2/JH gene rearrangement is undetectable in Hodgkin's lymphomas: results from the German Hodgkin trial. Virchows Arch. 1995; 426: 37-41.
16. Miura I, Tamura A, Taniwaki M etal. Detection of t(14;18)(q32;q21) in hyperdiploid cells by fluorescence in situ hybridization in a patient with Hodgkin disease. Cancer Genet Cytogenet 2000; 123: 97-101.
17. Schmitt C, Balogh B, Grundt A etal. The bcl-2/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity. Leuk Res 2006; 30: 745-50.
18. Cleary ML, Chao J, Warnke R etal. Immunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma. Proc Natl Acad Sci U S A 1984; 81: 593-7.
19. Custer RP, Bernhard WG. The interrelationship of Hodgkin's disease and other lymphatic tumors. Am J Med Sci 1948; 216: 625-42.
20. Bräuninger A, Hansmann ML, Strickler JG etal. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med 1999; 340: 1239-47.
21. Marafioti T, Hummel M, Foss HD etal. Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 2000; 95: 1443-50.
22. Bakhshi A, Wright JJ, Graninger W etal. Mechanism of the t(14;18) chromosomal translocation: structural analysis of both derivative 14 and 18 reciprocal partners. Proc Natl Acad Sci U S A 1987; 84: 2396-400.
23. Schwering I, Bräuninger A, Klein U etal. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 2003; 101: 1505-12.
24. Tracey L, Pérez-Rosado A, Artiga MJ etal. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively. J Pathol 2005; 206: 123-34.
25. Feuillard J, Schuhmacher M, Kohanna S etal. Inducible loss of NF-kappaB activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes. Blood 2000; 95: 2068-75.
26. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999; 18: 6853-66.
27. Kuppers R. The biology of Hodgkin's lymphoma. Nat Rev Cancer 2009; 9: 15-27.